Guangdong Marubi Biotechnology Co (SHSE:603983) Cyclically Adjusted PS Ratio: (As of Aug. 31, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603983 Guangdong Marubi Biotechnology Co Ltd SHSE:603983
84 GF Score
Price ¥28.55
GF Value ¥45.75
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Guangdong Marubi Biotechnology Co Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Guangdong Marubi Biotechnology Co  (SHSE:603983) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Guangdong Marubi Biotechnology Co Cyclically Adjusted PS Ratio Related Terms


Guangdong Marubi Biotechnology Co Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Guangdong Marubi Biotechnology Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangdong Marubi Biotechnology Co Cyclically Adjusted PS Ratio Chart

Guangdong Marubi Biotechnology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Guangdong Marubi Biotechnology Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 4.53 0.00

SHSE:603983 vs PG, CL, EL: Cyclically Adjusted PS Ratio Comparison

For the Household & Personal Products subindustry, Guangdong Marubi Biotechnology Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guangdong Marubi Biotechnology Co Cyclically Adjusted PS Ratio vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Marubi Biotechnology Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Guangdong Marubi Biotechnology Co's Cyclically Adjusted PS Ratio falls into.


SHSE:603983
84GF Score
Guangdong Marubi Biotechnology Co Ltd SHSE:603983
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangdong Marubi Biotechnology Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Guangdong Marubi Biotechnology Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Guangdong Marubi Biotechnology Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=1.988/116.0564*116.0564
=1.988

Current CPI (Jun. 2026) = 116.0564.

Guangdong Marubi Biotechnology Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201212 0.000 95.237 0.000
201312 0.000 97.624 0.000
201412 0.000 99.000 0.000
201512 0.000 100.600 0.000
201612 0.000 102.600 0.000
201712 0.000 104.500 0.000
201803 0.943 105.300 1.039
201806 1.074 104.900 1.188
201809 1.755 106.600 1.911
201812 1.396 106.500 1.521
201903 1.001 107.700 1.079
201906 1.258 107.700 1.356
201909 1.004 109.800 1.061
201912 1.500 111.200 1.566
202003 0.935 112.300 0.966
202006 1.047 110.400 1.101
202009 0.836 111.700 0.869
202012 1.541 111.500 1.604
202103 1.009 112.662 1.039
202106 1.161 111.769 1.206
202109 0.640 112.215 0.662
202112 1.698 113.108 1.742
202203 0.935 114.335 0.949
202206 1.091 114.558 1.105
202209 0.831 115.339 0.836
202212 1.399 115.116 1.410
202303 1.212 115.116 1.222
202306 1.461 114.558 1.480
202309 1.134 115.339 1.141
202312 1.796 114.781 1.816
202403 1.674 115.227 1.686
202406 1.696 114.781 1.715
202409 1.532 115.785 1.536
202412 2.460 114.893 2.485
202503 2.132 115.116 2.149
202506 2.217 114.907 2.239
202509 1.766 115.471 1.775
202512 2.550 115.832 2.555
202603 2.181 116.303 2.176
202606 1.988 116.056 1.988

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Guangdong Marubi Biotechnology Co (SHSE:603983) Overvalued in 2026?

Based on GuruFocus' analysis, Guangdong Marubi Biotechnology Co stock appears to be undervalued. The current stock price of ¥28.55 is trading 37.6% below its estimated GF Value™ of ¥45.75. GuruFocus considers Guangdong Marubi Biotechnology Co to be Significantly Undervalued.

Key valuation signals for SHSE:603983:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ¥45.75 vs. price of ¥28.55 (37.6% below fair value)
  • GF Score™: 84/100 with 4 warning signs

No single metric tells the full story. See the SHSE:603983 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Guangdong Marubi Biotechnology Co Business Description

Address No. 92, Peihe Road, Building 2, Science City, High-tech Industrial Development Zone, Guangdong Province, Guangzhou, CHN, 510000
Guangdong Marubi Biotechnology Co Ltd is engaged in the research and development, design, production, sales and service of various types of cosmetics.
84GF Score

Get the complete analysis for SHSE:603983

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥28.55
Price
¥45.75
GF Value